Beta-blockers in HFrEF (CIBIS-II, COPERNICUS, US Carvedilol HF study, MERIT-HF) — NERDCAT
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología
Abstract 9811: A Novel Analysis of Patient, Provider, and Utilization Factors Associated With an Electronic Health Record (EHR)-Embedded Guideline-Directed Medical Therapy Score | Circulation
Pharmacokinetic parameters of bisoprolol after a single 4 × 2.5-mg dose... | Download Table
Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects | SpringerLink
H. Moses Murdock on X: "4/ 🎯 What about target doses? CHAMP-HF showed we collectively do a poor job of optimizing GDMT. 👇🏾 https://t.co/cVqWpwXroP In their supplement, we find "Target Doses of